358 related articles for article (PubMed ID: 34591193)
1. Hemostatic efficacy of two topical adjunctive hemostats in a porcine spleen biopsy punch model of moderate bleeding.
MacDonald MH; Zhang G; Tasse L; Wang D; De Leon H; Kocharian R
J Mater Sci Mater Med; 2021 Sep; 32(10):127. PubMed ID: 34591193
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Hemostatic Efficacy of Two Powdered Topical Absorbable Hemostats Using a Porcine Liver Abrasion Model of Mild to Moderate Bleeding.
MacDonald MH; Tasse L; Wang D; Zhang G; De Leon H; Kocharian R
J Invest Surg; 2021 Nov; 34(11):1198-1206. PubMed ID: 32928005
[TBL] [Abstract][Full Text] [Related]
3. An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model.
Hutchinson RW; Werrlein S; Johns DB; Zhang G; Clymer JW; Kocharian R
Surg Technol Int; 2015 Nov; 27():53-7. PubMed ID: 26680379
[TBL] [Abstract][Full Text] [Related]
4. An Efficacy Comparison of Two Hemostatic Agents in a Porcine Liver Bleeding Model: Gelatin/Thrombin Flowable Matrix versus Collagen/Thrombin Powder.
Slezak P; Keibl C; Redl H; Labahn D; Gulle H
J Invest Surg; 2020 Oct; 33(9):828-838. PubMed ID: 30907197
[No Abstract] [Full Text] [Related]
5. Efficacy of Topical Hemostatic Agents: A Comparative Evaluation of Two Gelatin/Thrombin-Based Hemostatic Matrices in a Porcine Kidney Surgical Model.
Slezak P; Heher P; Monforte X; Keibl C; Redl H; Spazierer D; Gulle H
J Invest Surg; 2019 Nov; 32(7):646-653. PubMed ID: 29561208
[No Abstract] [Full Text] [Related]
6. Similar patient outcomes yet different hospital costs between flowable hemostatic agents.
David G; Lim S; Gunnarsson C; Kocharian R; Roy S
J Med Econ; 2015; 18(9):735-45. PubMed ID: 25907200
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic efficacy of EVARREST™, Fibrin Sealant Patch vs. TachoSil® in a heparinized swine spleen incision model.
Matonick JP; Hammond J
J Invest Surg; 2014 Dec; 27(6):360-5. PubMed ID: 25361019
[TBL] [Abstract][Full Text] [Related]
8. A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agent.
Cole DJ; Connolly RJ; Chan MW; Schwaitzberg SD; Byrne TK; Adams DB; Baron PL; O'Brien PH; Metcalf JS; Demcheva M; Vournakis J
Surgery; 1999 Sep; 126(3):510-7. PubMed ID: 10486603
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a gelatin matrix as a topical hemostatic agent for hepatic bleeding in the dog.
Polidoro DP; Kass PH
J Am Anim Hosp Assoc; 2013; 49(5):308-17. PubMed ID: 23861265
[TBL] [Abstract][Full Text] [Related]
10. Topical application of the hematostatic agent Surgiflo® could attenuate brain injury in experimental TBI mice.
Guo D; Li D; Li J; Li Y; Hu X; Guan F; Yang B
Neurol Res; 2017 Sep; 39(9):830-836. PubMed ID: 28566060
[TBL] [Abstract][Full Text] [Related]
11. An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models.
MacDonald MH; Wang AY; Clymer JW; Hutchinson RW; Kocharian R
Med Devices (Auckl); 2017; 10():273-279. PubMed ID: 29238233
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel hemostatic device in an ovine parenchymal organ bleeding model of normal and impaired hemostasis.
Turner AS; Parker D; Egbert B; Maroney M; Armstrong R; Powers N
J Biomed Mater Res; 2002; 63(1):37-47. PubMed ID: 11787027
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic efficiency of modern topical sealants: Comparative evaluation after liver resection and splenic laceration in a swine model.
Fonouni H; Kashfi A; Majlesara A; Stahlheber O; Konstantinidis L; Gharabaghi N; Kraus TW; Mehrabi A; Oweira H
J Biomed Mater Res B Appl Biomater; 2018 Apr; 106(3):1307-1316. PubMed ID: 28644516
[TBL] [Abstract][Full Text] [Related]
14. Real-world outcomes of hemostatic matrices in cardiac surgery.
Tackett SM; Calcaterra D; Magee G; Lattouf OM
J Cardiothorac Vasc Anesth; 2014 Dec; 28(6):1558-65. PubMed ID: 25245578
[TBL] [Abstract][Full Text] [Related]
15. Improved bleeding scores using Gelfoam(®) Powder with incremental concentrations of bovine thrombin in a swine liver lesion model.
Morse DC; Silva E; Bartrom J; Young K; Bass EJ; Potter D; Bieber T
J Thromb Thrombolysis; 2016 Oct; 42(3):352-9. PubMed ID: 27334382
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model.
Lewis KM; Atlee HD; Mannone AJ; Dwyer J; Lin L; Goppelt A; Redl H
J Invest Surg; 2013 Jun; 26(3):141-8. PubMed ID: 23514063
[TBL] [Abstract][Full Text] [Related]
17. Hemostatic efficacy of a recombinant thrombin-coated polyglycolic acid sheet coupled with liquid fibrinogen, evaluated in a canine model of pulmonary arterial hemorrhage.
Izumi Y; Gika M; Shinya N; Miyabashira S; Imamura T; Nozaki C; Kawamura M; Kobayashi K
J Trauma; 2007 Oct; 63(4):783-7; discussion 787. PubMed ID: 18090006
[TBL] [Abstract][Full Text] [Related]
18. Use of fibrin-based sealants and gelatin-matrix hemostats in laparoscopic liver surgery.
Saif R; Jacob M; Robinson S; Amer A; Kei-Hui D; Sen G; Manas D; White S
Surg Laparosc Endosc Percutan Tech; 2011 Jun; 21(3):131-41. PubMed ID: 21654294
[TBL] [Abstract][Full Text] [Related]
19. A gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery.
Woodworth BA; Chandra RK; LeBenger JD; Ilie B; Schlosser RJ
Am J Otolaryngol; 2009; 30(1):49-53. PubMed ID: 19027513
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of thrombin loaded TEMPO-oxidized cellulose nanofiber-gelatin sponges and their hemostatic behavior in rat liver hemorrhage model.
Ibne Mahbub MS; Sultana T; Gwon JG; Lee BT
J Biomater Sci Polym Ed; 2022 Mar; 33(4):499-516. PubMed ID: 34644247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
